Delaware jury awards $96.3m damages to Natera over kidney transplant tests

Biotech firm CareDx found to have infringed one of two patents-in-suit through sale of AlloSure and AlloSeq | Damages award consists of $83.6m in lost profits and $12.6m in royalties.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Abbott clinches 18-country PI in glucose monitoring feud

9 September 2026 The UPC has handed the medical device company a significant win over continuous glucose monitoring tech, granting a broad provisional injunction after finding that SiBio’s rival system was likely to infringe its European patent.

MedTech

Sun Pharma import ban back in force after Squires intervention

3 September 2026 A decision at the USPTO has cleared the way for renewed enforcement in the drugmaker’s dispute over light-based dermatology tech.

MedTech

Abbott fends off Chinese rival’s patent challenge at UPC

18 August 2026 The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue.

More features

Built to be bought? What makes companies acquisition-ready

Patent lawyers and judges discuss lofty UPC issues in grand London venue

J&J names two-decade veteran as chief IP counsel

J&J unit win shuts door on Sandoz generic launch

Abbott clinches 18-country PI in glucose monitoring feud

UK firm hires head of IP with commercial and technical nous

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

G 1/25: EPO settles controversial patent description question

Delaware jury awards $96.3m damages to Natera over kidney transplant tests

More on this story

Editor's picks

Editor's picks

More features